AKT1 and neoplasm: Figure 11 shows the top 10 significantly enriched pathways, including glycolysis/gluconeogenesis, HIF-1 signaling, PI3K-Akt signaling, and immune evasion all hallmarks of tumor progression and therapeutic resistance.